Mithra

Mithra and Searchlight Pharma Announce Donesta® Licensing Agreement for Canada

Retrieved on: 
Monday, July 31, 2023
Health, Consumer, Women, General Health, Clinical Trials, Pharmaceutical, Biotechnology, Partnership, Development, Woman, Multimedia, MITRA, Trust, Estrogen, Brussels Stock Exchange, Menopause, Safety, Pharmaceutical industry, Birth control, Mithra, Estetrol

View the full release here: https://www.businesswire.com/news/home/20230731182336/en/

Key Points: 
  • View the full release here: https://www.businesswire.com/news/home/20230731182336/en/
    Under the binding terms, Searchlight will have the exclusive sales and marketing rights for Donesta® in Canada.
  • Searchlight will be responsible for obtaining and maintaining any regulatory approvals required to market and sell Donesta® in Canada.
  • David Horn Solomon, Chief Executive Officer of Mithra, commented: “We are very pleased to reach this agreement with Searchlight Pharma for the licensing of Donesta® in Canada.
  • Mithra and Searchlight have a continuing partnership for NEXTSTELLIS®, a combined oral contraceptive product based on Estetrol, and HALOETTE®, a vaginal contraceptive ring in Canada.

Mithra and Searchlight Pharma Announce Donesta® Licensing Agreement for Canada

Retrieved on: 
Monday, July 31, 2023
Partnership, Drug development, Development, Birth, Woman, Liège, MITRA, Trust, CEST, Estrogen, Brussels Stock Exchange, Menopause, Health, Safety, Pharmaceutical industry, Birth control, Mithra, Estetrol, Euronext

Under the binding terms, Searchlight will have the exclusive sales and marketing rights for Donesta® in Canada.

Key Points: 
  • Under the binding terms, Searchlight will have the exclusive sales and marketing rights for Donesta® in Canada.
  • Searchlight will be responsible for obtaining and maintaining any regulatory approvals required to market and sell Donesta® in Canada.
  • David Horn Solomon, Chief Executive Officer of Mithra, commented: “We are very pleased to reach this agreement with Searchlight Pharma for the licensing of Donesta® in Canada.
  • Mithra and Searchlight have a continuing partnership for NEXTSTELLIS®, a combined oral contraceptive product based on Estetrol and HALOETTE®, a vaginal contraceptive ring in Canada.

Mithra - Letter to Shareholders and Corporate Update

Retrieved on: 
Thursday, May 25, 2023
Highbridge, Gedeon Richter, Letter, Mayo Clinic, Drawing, Endometrium, Therapy, Arthralgia, File, Marketing, Birth, Silence Therapeutics, NDA, BL 2.75-inch mountain gun, Ageing, Woman, Quality of life, Hospira, Research, Negotiation, Attention, Brain, DRSP, Hot, GSI, MITRA, Incidence, Communication, EUR, Dementia, CDMO, System, Patient, CEST, Estrogen, Brussels Stock Exchange, Menopause, Liver, Growth, Mortality, MAA, FDA, Zealand Pharma, Management, Risk management, Pharmaceutical industry, Medical device, Security (finance), Mithra, Estetrol, White box

Donesta® filing rescheduled for H2 2023 - still expecting U.S. approval in H1 2024

Key Points: 
  • Donesta® filing rescheduled for H2 2023 - still expecting U.S. approval in H1 2024
    Liege, Belgium, 25 May 2023 – 7:30 CEST – Mithra (Euronext Brussels: MITRA), a company dedicated to Women’s Health, (the "Company" or "Mithra"), today published a Corporate Update and Letter to Shareholders from recently appointed Chief Executive Officer, Dr. David Horn Solomon.
  • I accepted the role because my analysis revealed strong fundamentals and tremendous potential to create significant value for Mithra shareholders.
  • Collectively, the Mithra leadership understands that our ability to create value for our shareholders is a primary directive that goes hand in hand with developing medicines for women.
  • I look forward to continuing with increased transparency and regular communications to providing updates on our progress to you, our shareholders.

Happiest Minds is among India's Top 15 Best Workplaces in Health and Wellness for 2021

Retrieved on: 
Monday, March 28, 2022
Wellness, Company, NSE, Trust, Organization, WNBA's Top 15 Players of All Time, Workplace wellness, Leadership, Blockchain, BFSI, Ownership, Equality, Research, Born Digital, Mindfulness, Philosophy, Communication, Self-assessment, Diversity, Artificial intelligence, Inclusion, Digital, Mithra, Internal, Alternative medicine, Efficiency, Workplace, Internet, Engineering, Management, Health

Born Agile' digital transformation and IT solutions company, today announced being recognized among the Top 15 of India's Best Workplaces in Health and Wellness for 2021 by Great Place to Work Institute (GPTW),the global authority on high-trust workplace culture.

Key Points: 
  • Born Agile' digital transformation and IT solutions company, today announced being recognized among the Top 15 of India's Best Workplaces in Health and Wellness for 2021 by Great Place to Work Institute (GPTW),the global authority on high-trust workplace culture.
  • Following a rigorous and comprehensive assessment, Happiest Minds has emerged as one of the most desirable workplaces which takes extensive efforts to percolate and imbibe its core values and philosophy.
  • Joseph Anantharaju, Executive Vice Chairman, Happiest Minds Technologies said,"We are honored to be recognized as one of the Top 15 best workplaces in India for Health and Wellness.
  • A Great Place to Work-Certified company, Happiest Minds is headquartered in Bangalore, India, with operations in the U.S., UK, Canada, Australia, and the Middle East.

Happiest Minds is among India's Top 15 Best Workplaces in Health and Wellness for 2021

Retrieved on: 
Monday, March 28, 2022
Wellness, Company, NSE, Trust, Organization, WNBA's Top 15 Players of All Time, Workplace wellness, Leadership, Blockchain, BFSI, Ownership, Equality, Research, Born Digital, Mindfulness, Philosophy, Communication, Self-assessment, Diversity, Artificial intelligence, Inclusion, Digital, Mithra, Internal, Alternative medicine, Efficiency, Workplace, Internet, Engineering, Management, Health

Born Agile' digital transformation and IT solutions company, today announced being recognized among the Top 15 of India's Best Workplaces in Health and Wellness for 2021 by Great Place to Work Institute (GPTW),the global authority on high-trust workplace culture.

Key Points: 
  • Born Agile' digital transformation and IT solutions company, today announced being recognized among the Top 15 of India's Best Workplaces in Health and Wellness for 2021 by Great Place to Work Institute (GPTW),the global authority on high-trust workplace culture.
  • Following a rigorous and comprehensive assessment, Happiest Minds has emerged as one of the most desirable workplaces which takes extensive efforts to percolate and imbibe its core values and philosophy.
  • Joseph Anantharaju, Executive Vice Chairman, Happiest Minds Technologies said,"We are honored to be recognized as one of the Top 15 best workplaces in India for Health and Wellness.
  • A Great Place to Work-Certified company, Happiest Minds is headquartered in Bangalore, India, with operations in the U.S., UK, Canada, Australia, and the Middle East.

ExeVir and Mithra announce manufacturing collaboration for innovative Covid-19 treatments

Retrieved on: 
Thursday, July 15, 2021
Mithra, Yazatas, Fill and finish, Economic sectors, Economic taxonomy

ExeVir launched less than one year ago and has made tremendous progress in building the company and an innovative pipeline.

Key Points: 
  • ExeVir launched less than one year ago and has made tremendous progress in building the company and an innovative pipeline.
  • Under the terms of the collaboration, Mithra will be responsible for upscalingand manufacturing services for filling the drug substance in support of clinical and commercial supply.
  • Torsten Mummenbrauer, CEO of ExeVir Bio, said: "We are very pleased to collaborate with Mithra which has built a cutting-edge new fill and finish manufacturing facility.
  • Renaat Baes, Chief Manufacturing Officer of Mithra, commented:"We are absolutely thrilled to enter into this collaboration agreement with ExeVir, who is developing promising innovative Covid-19 treatments.

ExeVir and Mithra announce manufacturing collaboration for innovative Covid-19 treatments

Retrieved on: 
Thursday, July 15, 2021
Mithra, Yazatas, Fill and finish, Economic sectors, Economic taxonomy

ExeVir launched less than one year ago and has made tremendous progress in building the company and an innovative pipeline.

Key Points: 
  • ExeVir launched less than one year ago and has made tremendous progress in building the company and an innovative pipeline.
  • Under the terms of the collaboration, Mithra will be responsible for upscalingand manufacturing services for filling the drug substance in support of clinical and commercial supply.
  • Torsten Mummenbrauer, CEO of ExeVir Bio, said: "We are very pleased to collaborate with Mithra which has built a cutting-edge new fill and finish manufacturing facility.
  • Renaat Baes, Chief Manufacturing Officer of Mithra, commented:"We are absolutely thrilled to enter into this collaboration agreement with ExeVir, who is developing promising innovative Covid-19 treatments.

DGAP-News: Alychlo to sell shares in Mithra Pharmaceuticals by means of a private placement via an accelerated bookbuild offering

Retrieved on: 
Wednesday, March 31, 2021
Stock market, Placement, Investment, Mithra, Book building, Private placement

Alychlo N.V. ("Alychlo") announces today its intention to sell approximately 1.5 million existing ordinary shares in Mithra Pharmaceuticals SA ("Mithra") to institutional investors by means of a private placement via an accelerated bookbuild offering ("Private Placement").

Key Points: 
  • Alychlo N.V. ("Alychlo") announces today its intention to sell approximately 1.5 million existing ordinary shares in Mithra Pharmaceuticals SA ("Mithra") to institutional investors by means of a private placement via an accelerated bookbuild offering ("Private Placement").
  • Following the Private Placement, Alychlo, together with Marc Coucke, will hold approximately 11.6% of Mithra's current outstanding share capital.
  • The bookbuilding will open immediately after publication of this press release and may close at short notice.
  • In the context of the Private Placement, Alychlo has agreed to a lock-up undertaking in relation to its residual holding in Mithra ending 180 days after the closing date, subject to customary exceptions.

Mithra Reports Full Year 2019 Financial Results

Retrieved on: 
Monday, March 9, 2020
Hormones, Mitra, Oaths, Mithra, Estetrol, International Financial Reporting Standards, Euronext, Drugs, Organ systems

Record revenue (EUR 96.5 million) and EBITDA (EUR 40.7 million) increased respectively by 47% and 6%, mainly driven by U.S. deal for Estelle

Key Points: 
  • Record revenue (EUR 96.5 million) and EBITDA (EUR 40.7 million) increased respectively by 47% and 6%, mainly driven by U.S. deal for Estelle
    Key milestones achieved for environmental-friendly E4-based portfolio pipeline, with successful launch of Phase III study of Donesta in menopause and regulatory submission of Estelle in Europe
    Liege, Belgium, 09 March 2020 7:30 CET Mithra (Euronext Brussels: MITRA), a company dedicated to Womens Health, today announces its financial results for the year ended 31 December 2019, prepared in accordance with IFRS.
  • Mithra will host a conference call and live webcast today (March 9, 2020) at 15:00 CET/9:00 EST.
  • The live webcast can be accessed on the Mithra website or by clicking here

ShelterZoom Invents New Method for Creating and Executing Contracts on Blockchain

Retrieved on: 
Tuesday, April 9, 2019
Technology, Internet, Networks, Software, Professional services, Finance, Legal, Cryptocurrencies, Decentralization, Articles, Computing, Technology, Blockchain, Encodings, Ricardian contract, Mithra

Mithra Contract represents an evolution from existing paper, smart and Ricardian contracts.

Key Points: 
  • Mithra Contract represents an evolution from existing paper, smart and Ricardian contracts.
  • The release of Mithra Contract, ShelterZoom Mithra Coins and Mithra Tokens signals the beginning of a new digital era of deal, contract and transaction management, said Chao Cheng-Shorland and Allen Alishahi, ShelterZoom co-founders.
  • ShelterZoom is doing important innovation in real estate and blockchain, said Lee A. Schneider, co-founder of Genesis Block.
  • The blockchain ecosystem needs companies like ShelterZoom to continue to push the technology and its applications forward in ways that are useful for people and commerce.